Comparative Effectiveness Bill Allows Industry Input Into Study Selection
This article was originally published in The Tan Sheet
Executive Summary
A bill introduced in the House would prevent the government from being the sole director of comparative effectiveness research by setting up an independent institute overseen by a broad array of stakeholders, including industry
You may also be interested in...
Baucus Bill Takes “Patient-Centered” Focus For Comparative Effectiveness
The latest comparative effectiveness legislation from Sen. Max Baucus suggests an approach that might be more welcome to the pharma industry
Comparative Effectiveness Language Clarified In Compromise Stimulus Bill
Congress took steps in its final version of the economic stimulus package to alleviate concerns that the comparative effectiveness research provisions will lead to the government making cost-based comparisons or making coverage and reimbursement decisions based on the research
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.